DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

Benzer Materyaller

• Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
  Yazar:: Jyoti Nangalia
  Baskı/Yayın Bilgisi: (2019-06-01)
• Mutant Calreticulin in the Myeloproliferative Neoplasms
  Yazar:: Daniel Prins, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-02-01)
• DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
  Yazar:: Jyoti Nangalia, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-11-01)
• Pathogenesis and management of high molecular risk myeloproliferative neoplasms
  Yazar:: Victoria Y. Ling, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)
• Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
  Yazar:: Sylvie Hermouet, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-01-01)